(Q34623728)

English

Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

based on heuristic

inferred from title

Tomas Andrasina

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Kelly M. McMasters

7

object named as

Kelly M McMasters

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Charles R. Scoggins

8

object named as

Charles R Scoggins

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Robert C G Martin

9

object named as

Robert C G Martin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Suzanne C Schiffman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Tiffany Metzger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Gregory Dubel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ivan Kralj

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Cliff Tatum

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

16 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

431-438

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Surgical management of intrahepatic cholangiocarcinoma--a population-based study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Current status of intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Recurrence after surgical resection of intrahepatic cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

The role of chemotherapy in cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

RECIST revisited: a review of validation studies on tumour assessment

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1333-4

21 January 2018

Identifiers

10.1245/S10434-010-1333-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20862554%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34623728&oldid=2196880884"